3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
107
Lung Neoplasms
41
Neoplasms
13
Neoplasm Metastasis
11
Colorectal Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Pancreatic Neoplasms
6
Carcinoma
6
Mesothelioma, Malignant
5
Mesothelioma
5
Ovarian Neoplasms
4
Meningeal Carcinomatosis
4
Melanoma
4
Colonic Neoplasms
4
Advanced Solid Tumors
4
Rectal Neoplasms
3
Neoplasms by Site
3
Lung Diseases
3
Carcinoma, Bronchogenic
3
Adenocarcinoma of Lung
3
Adenocarcinoma
3
Uterine Cervical Neoplasms
2
Thoracic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Respiratory Tract Neoplasms
2
Respiratory Tract Diseases
2
Non-squamous Non-small Cell Lung Cancer
2
Non-Small Cell Lung Cancer Metastatic
2
Non Small Cell Lung Carcinoma NSCLC
2
Interventions
Etoposide
3
Carboplatin
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
Paclitaxel
2
Cyclophosphamide
2
Cisplatin
2
repotrectinib
1
pralsetinib
1
lutetium Lu 177 dotatate
1
Vorinostat
1
Standard of Care
1
Specimen Handling
1
Respiratory Physiological Phenomena
1
Practice Guidelines as Topic
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Ifosfamide
1
Gemcitabine
1
Cytapheresis
1
Bleomycin
1
Biopsy
1
Automobiles
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Pemetrexed
×
90 days
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts